BBVA USA’s Neogen NEOG Stock Holding History

BBVA USA’s Portfolio NEOG Stock Details NEOG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$53K	Hold	1,222	–	–	﹤0.01%	648
2021 Q2	$56K	Buy	+1,222	New	+$56.5K	﹤0.01%	657

Other funds holding NEOG

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BBVA USA's NEOG Position: Q3 2021 in Review

BBVA USA held its Neogen (NEOG) position steady in Q3 2021 at 1,222 shares worth $53K. The position accounts for ﹤0.01% of the portfolio, ranked #648.

BBVA USA first reported a position in NEOG in Q2 2021 and has held it in 2 quarters since. The position peaked at $56K in Q2 2021. 303 funds tracked by Wall St. Rank hold NEOG as of Q3 2021.

BBVA USA held 1,222 shares of Neogen worth $53K as of Q3 2021.
BBVA USA left its Neogen share count unchanged in Q3 2021.
Neogen made up ﹤0.01% of BBVA USA's portfolio in Q3 2021, its #648 holding.
BBVA USA first reported a position in Neogen in Q2 2021 and has held it in 2 quarters since.
BBVA USA's Neogen position peaked at $56K in Q2 2021.
303 funds tracked by Wall St. Rank held Neogen as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.